Table 1

Comparison of treated and control patient pretreatment parameters

ParameterControl (n = 18)aTreated (n = 18)b
Mean ± SDc
Age at Surgery (yr)60 ± 5.360.5 ± 6.6c
PSA (μg/liter)8.7 ± 5.89.3 ± 7.0c
Gleason score6.1 ± 1.36.6 ± 0.9c
Clinical Staged
n (%) patients
TNM staging
NX, N1, M000
T1c12 (66.7)10 (55.6)
T2a3 (16.7)4 (22.2)
T2b3 (16.7)4 (22.2)
T2c00
T3a00
T3b00
T400
  • a n = 18 matched controls.

  • b n = 18 excluding patients ID 4 and ID 10 from treated group.

  • c Two sample t tests, control versus treated, not significant.

  • d All patients were N0, M0 unless otherwise stated.